Search

A Look Back to WeConnect's Article on Our Queen's Award Win.


This blog post is taken from the WeConnect website, posted by Maggie Berry on 24 Apr 2015.

Zigzag Associates Limited (‘Zigzag’), one of our certified women-owned businesses providing quality assurance services to the pharmaceutical and biotechnology industries, has been awarded the Queen’s Award for International Trade. The award was made for achieving outstanding growth in its export earnings of 316% in the last three years.

Founded in January 2010, Zigzag operates as an independent auditing and consultancy company for the industry, ensuring that clients adhere to required regulatory standards and that procedures are followed. Initially Zigzag primarily worked for UK-based clients, operating mainly in the UK and some mainland European countries. In the last three years Zigzag has expanded its client base to include large US and Japanese companies and now offers auditing services globally through a network of locally based consultants. This business model has proved to be highly successful and over the past three years Zigzag has audited in over 70 countries around the world.

Julie Beal, Managing Director, Global Client Services, said:

“We are extremely pleased to receive the recognition of a Queen’s Award for all the hard work building Zigzag into a truly international company. This is a proud moment for the Company and all our staff."

About Zigzag Associates Ltd More details of the company and Zigzag’s services can be found at www.zigzagassociates.com

Note: Image has been edited to reflect current staff. Website has been edited to reflect current urll.

#Queensawardforenterprise #internationaltrade #weconnect

0 comments

Recent Posts

See All

Conducting Pharmacovigilance audits during COVID-19

Considering the current global health pandemic known as COVID-19, the pharmaceutical industry has a real life scenario to test out the business continuity planning of the Pharmacovigilance (PV) operat

EMA COVID-19 Guidance and Auditing activities

With the outbreak of the COVID-19 virus the European Medicines Agency (EMA) issued guidance on 20th March 2020 for conducting Clinical Trials during the Pandemic. While the guidance was primarily focu

Deciding to audit remotely?

Drug companies are continuously striving to reduce and streamline clinical drug development. However, with the current pandemic precautions, increasing pressures to reduce climate impact, political un